Growing community of inventors

Auburn, NH, United States of America

Sheila DeWitt

Average Co-Inventor Count = 1.34

ph-index = 7

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 199

Sheila DeWittVincent Jacques (8 patents)Sheila DeWittLeonardus Van Der Ploeg (4 patents)Sheila DeWittLeonardus H T Van Der Ploeg (2 patents)Sheila DeWittSébastien Bolze (1 patent)Sheila DeWittLaure Françoise Valérie Navarre (1 patent)Sheila DeWittEmeline Gardette (1 patent)Sheila DeWittLeonardus HT Van Der Ploeg (0 patent)Sheila DeWittSheila DeWitt (21 patents)Vincent JacquesVincent Jacques (29 patents)Leonardus Van Der PloegLeonardus Van Der Ploeg (4 patents)Leonardus H T Van Der PloegLeonardus H T Van Der Ploeg (32 patents)Sébastien BolzeSébastien Bolze (11 patents)Laure Françoise Valérie NavarreLaure Françoise Valérie Navarre (2 patents)Emeline GardetteEmeline Gardette (1 patent)Leonardus HT Van Der PloegLeonardus HT Van Der Ploeg (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Deuterx, LLC (14 from 23 patents)

2. Poxel Sa (5 from 12 patents)

3. Salarius Pharmaceuticals, Inc. (2 from 2 patents)


21 patents:

1. 11918569 - 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

2. 11820720 - 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deuteropiperidine-2,6-dione derivatives and compositions comprising and methods of using the same

3. 11773080 - Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating medical disorders using same

4. 11535603 - Deuterium-enriched piperidinonyl-oxoisoindolinyl acetamides and methods of treating medical disorders using same

5. 11491156 - 3-(substituted-4-oxoquinazolin-3(4)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

6. 11319313 - Crystalline forms of deuterium-enriched pioglitazone

7. 11141411 - Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone

8. 11123336 - 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

9. 11040925 - 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

10. 10555946 - 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

11. 10265305 - 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

12. 10202316 - 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

13. 10188639 - Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone

14. 9913845 - 3-(substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same

15. 9833445 - 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…